The expression of NMDA receptor 1 correlates with clinicopathological parameters in cutaneous squamous cell carcinoma

Annals of Dermatology

Volumn 21, Issue 4, 2009, Pages 382-388

  Kang, Minju ^a   Cho, Jae Hoon ^a   Koo, Ja Kyung ^a   Noh, Sun Up ^a   Kim, Mi Yeon ^a   Kang, Hoon ^a   Oh, Shin Taek ^a   Kim, Hyung Ok ^a   Park, Young Min ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Cutaneous squamous cell carcinoma; Differentiation; Metastasis; N methyl D aspartate receptor

Indexed keywords

EID: 75949090728     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2009.21.4.382     Document Type: Article

References (21)

1. Rzeski W, Turski L, Ikonomidou C. Glutamate antagonists limit tumor growth. Proc Natl Acad Sci U S A 2001;98:6372- 6377.
2. Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 2000;130: 1007S-1015S.
3. Watkins JC, Evans RH. Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol 1981;21:165-204.
4. Foldes RL, Rampersad V, Kamboj RK. Cloning and sequence analysis of cDNAs encoding human hippocampus N-meth-yl-D-aspartate receptor subunits: evidence for alternative RNA splicing. Gene 1993;131:293-298.
5. Skerry TM, Genever PG. Glutamate signalling in non-neuro- nal tissues. Trends Pharmacol Sci 2001;22:174-181.
6. Nahm WK, Philpot BD, Adams MM, Badiavas EV, Zhou LH, Butmarc J, et al. Significance of N-methyl-D-aspartate (NMDA) receptor-mediated signaling in human keratinocytes. J Cell Physiol 2004;200:309-317.
7. Fischer M, Glanz D, William T, Klapperstuck T, Wohlrab J, Marsch W. N-methyl-D-aspartate receptors influence the intracellular calcium concentration of keratinocytes. Exp Dermatol 2004;13:512-519.
8. Menon GK, Elias PM. Ultrastructural localization of calcium in psoriatic and normal human epidermis. Arch Dermatol 1991;127:57-63.
9. Fischer M, William T, Helmbold P, Wohlrab J, Marsch W. Expression of epidermal N-methyl-D-aspartate receptors (NMDAR1) depends on formation of the granular layer-analysis in diseases with parakeratotic cornification. Arch Dermatol Res 2004;296: 157-162.
10. North WG, Fay MJ, Du J, Cleary M, Gallagher JD, McCann FV. Presence of functional NMDA receptors in a human neuroblastoma cell line. Mol Chem Neuropathol 1997;30: 77-94.
11. Yoshioka A, Ikegaki N, Williams M, Pleasure D. Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cells lines. J Neurosci Res 1996;46: 164-178.
12. Broders AC. Squamous-cell epithelioma of the skin: a study of 256 cases. Ann Surg 1921;73: 141-160.
13. Maatkamp A, Vlug A, Haasdijk E, Troost D, French PJ, Jaarsma D. Decrease of Hsp25 protein expression precedes degeneration of motoneurons in ALS-SOD1 mice. Eur J Neurosci 2004;20: 14-28.
14. Choi SW, Park SY, Hong SP, Pai H, Choi JY, Kim SG. The expression of NMDA receptor 1 is associated with clin- icopathological parameters and prognosis in the oral squamous cell carcinoma. J Oral Pathol Med 2004;33:533-537.
15. Barksdale SK, O'Connor N, Barnhill R. Prognostic factors for cutaneous squamous cell and basal cell carcinoma. Determinants of risk of recurrence, metastasis, and development of subsequent skin cancers. Surg Oncol Clin N Am 1997; 6:625-638.
16. ohnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992;26:467-484.
17. . Kwa RE, Campana K, Moy RL. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992;26:1-26.
18. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992;26: 976-990.
19. Bernstein SC, Lim KK, Brodland DG, Heidelberg KA. The many faces of squamous cell carcinoma. Dermatol Surg 1996;22:243-254.
20. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001;344:975-983.
21. Eriksen JG, Steiniche T, Askaa J, Alsner J, Overgaard J. The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 2004;58:561-566.